Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg.

MLA

Kelly, Aaron S., et al. “Reducing BMI below the Obesity Threshold in Adolescents Treated with Once-Weekly Subcutaneous Semaglutide 2.4 Mg.” Obesity (Silver Spring, Md.), vol. 31, no. 8, Aug. 2023, pp. 2139–49. EBSCOhost, https://doi.org/10.1002/oby.23808.

APA

Kelly, A. S., Arslanian, S., Hesse, D., Iversen, A. T., Körner, A., Schmidt, S., Sørrig, R., Weghuber, D., & Jastreboff, A. M. (2023). Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg. Obesity (Silver Spring, Md.), 31(8), 2139–2149. https://doi.org/10.1002/oby.23808

Chicago

Kelly, Aaron S, Silva Arslanian, Dan Hesse, Aske Thorn Iversen, Antje Körner, Signe Schmidt, Rasmus Sørrig, Daniel Weghuber, and Ania M Jastreboff. 2023. “Reducing BMI below the Obesity Threshold in Adolescents Treated with Once-Weekly Subcutaneous Semaglutide 2.4 Mg.” Obesity (Silver Spring, Md.) 31 (8): 2139–49. doi:10.1002/oby.23808.